309 related articles for article (PubMed ID: 12909235)
1. Patterns of failure after the multimodality treatment of uterine papillary serous carcinoma.
Sood BM; Jones J; Gupta S; Khabele D; Guha C; Runowicz C; Goldberg G; Fields A; Anderson P; Vikram B
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):208-16. PubMed ID: 12909235
[TBL] [Abstract][Full Text] [Related]
2. Uterine papillary serous carcinoma. A clinical study.
Gitsch G; Friedlander ML; Wain GV; Hacker NF
Cancer; 1995 May; 75(9):2239-43. PubMed ID: 7712431
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin, doxorubicin hydrochloride, and cyclophosphamide followed by radiotherapy in high-risk endometrial carcinoma.
Smith MR; Peters WA; Drescher CW
Am J Obstet Gynecol; 1994 Jun; 170(6):1677-81; discussion 1681-2. PubMed ID: 8203425
[TBL] [Abstract][Full Text] [Related]
4. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
5. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma.
Hendrickson M; Ross J; Eifel P; Martinez A; Kempson R
Am J Surg Pathol; 1982 Mar; 6(2):93-108. PubMed ID: 7102898
[TBL] [Abstract][Full Text] [Related]
6. Uterine papillary serous carcinoma (UPSC) treated with cisplatin, doxorubicin, and cyclophosphamide (PAC).
Levenback C; Burke TW; Silva E; Morris M; Gershenson DM; Kavanagh JJ; Wharton JT
Gynecol Oncol; 1992 Sep; 46(3):317-21. PubMed ID: 1526508
[TBL] [Abstract][Full Text] [Related]
7. Uterine papillary serous carcinoma treated with intraperitoneal cisplatin and intravenous doxorubicin and cyclophosphamide.
Chambers JT; Chambers SK; Kohorn EI; Carcangiu ML; Schwartz PE
Gynecol Oncol; 1996 Mar; 60(3):438-42. PubMed ID: 8774654
[TBL] [Abstract][Full Text] [Related]
8. Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival.
Carcangiu ML; Chambers JT
Int J Gynecol Pathol; 1995 Jan; 14(1):30-8. PubMed ID: 7883423
[TBL] [Abstract][Full Text] [Related]
9. Intravenous cisplatin, doxorubicin, and cyclophosphamide in the treatment of uterine papillary serous carcinoma (UPSC).
Price FV; Chambers SK; Carcangiu ML; Kohorn EI; Schwartz PE; Chambers JT
Gynecol Oncol; 1993 Dec; 51(3):383-9. PubMed ID: 8112650
[TBL] [Abstract][Full Text] [Related]
10. [Uterine papillary serous carcinoma--one kind of special type of uterine endometrial carcinoma].
Wu M; Lang J; Guo L
Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):3-7. PubMed ID: 8758809
[TBL] [Abstract][Full Text] [Related]
11. [Uterine papillary serous carcinoma and papillary endometrial carcinoma: analysis of clinical biological behaviors of 56 cases].
Sun X; Shi S; Sheng X
Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):8-11. PubMed ID: 8758810
[TBL] [Abstract][Full Text] [Related]
12. Uterine papillary serous carcinoma: a study on 108 cases with emphasis on the prognostic significance of associated endometrioid carcinoma, absence of invasion, and concomitant ovarian carcinoma.
Carcangiu ML; Chambers JT
Gynecol Oncol; 1992 Dec; 47(3):298-305. PubMed ID: 1473741
[TBL] [Abstract][Full Text] [Related]
13. Analysis of failure patterns in stage III endometrial carcinoma and therapeutic implications.
Greven KM; Curran WJ; Whittington R; Fanning J; Randall ME; Wilder J; Peters AJ
Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):35-9. PubMed ID: 2745205
[TBL] [Abstract][Full Text] [Related]
14. The prognosis in early endometrial carcinoma. The importance of uterine papillary serous carcinoma (UPSC), age, FIGO grade and nuclear grade.
Rosenberg P; Risberg B; Askmalm L; Simonsen E
Acta Obstet Gynecol Scand; 1989; 68(2):157-63. PubMed ID: 2589042
[TBL] [Abstract][Full Text] [Related]
15. A new aggressive treatment approach to high-grade endometrial cancer of possible benefit to patients with stage I uterine papillary cancer.
Rosenberg P; Boeryd B; Simonsen E
Gynecol Oncol; 1993 Jan; 48(1):32-7. PubMed ID: 8423019
[TBL] [Abstract][Full Text] [Related]
16. Chemotherapeutic approach to uterine papillary serous carcinoma.
Hamaguchi K; Komai K; Sakihama H; Okura N; Nagasue N; Nishida T; Yakushiji M
Asia Oceania J Obstet Gynaecol; 1990 Dec; 16(4):367-72. PubMed ID: 2129190
[TBL] [Abstract][Full Text] [Related]
17. Influence of grade, histologic subtype, and timing of radiotherapy on outcome among patients with stage II carcinoma of the endometrium.
Lanciano RM; Curran WJ; Greven KM; Fanning J; Stafford P; Randall ME; Hanks GE
Gynecol Oncol; 1990 Dec; 39(3):368-73. PubMed ID: 2258085
[TBL] [Abstract][Full Text] [Related]
18. Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system.
Grigsby PW; Perez CA; Kuten A; Simpson JR; Garcia DM; Camel HM; Kao MS; Galakatos AE
Int J Radiat Oncol Biol Phys; 1992; 22(5):905-11. PubMed ID: 1555983
[TBL] [Abstract][Full Text] [Related]
19. Uterine papillary serous carcinoma (UPSC): a clinicopathologic study of 30 cases.
Kato DT; Ferry JA; Goodman A; Sullinger J; Scully RE; Goff BA; Fuller AF; Rice LW
Gynecol Oncol; 1995 Dec; 59(3):384-9. PubMed ID: 8522260
[TBL] [Abstract][Full Text] [Related]
20. A randomized phase III trial in advanced endometrial carcinoma of surgery and volume directed radiation followed by cisplatin and doxorubicin with or without paclitaxel: A Gynecologic Oncology Group study.
Homesley HD; Filiaci V; Gibbons SK; Long HJ; Cella D; Spirtos NM; Morris RT; DeGeest K; Lee R; Montag A
Gynecol Oncol; 2009 Mar; 112(3):543-52. PubMed ID: 19108877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]